Literature DB >> 24981895

[Update of the S3 guidelines for pancreatic cancer. What is new for pathologists?].

J Munding1, J Lüttges, I Esposito, A Tannapfel.   

Abstract

The S3 guidelines for pancreatic cancer were revised in 2013. Besides the oncological and palliative therapy modalities and surgical therapy, the guidelines for pathologists in topic 3 were updated. The modifications essentially concern the histopathological assessment of surgical specimens and in particular the circumferential resection margin and the R classification. In addition, the current recommendations were amended by recommendations concerning the pathohistological records, which should include the lymph node ratio in the future.

Entities:  

Mesh:

Year:  2014        PMID: 24981895     DOI: 10.1007/s00292-012-1712-7

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  23 in total

Review 1.  Resection margins and R1 rates in pancreatic cancer--are we there yet?

Authors:  C S Verbeke
Journal:  Histopathology       Date:  2007-12-13       Impact factor: 5.087

2.  Most pancreatic cancer resections are R1 resections.

Authors:  Irene Esposito; Jörg Kleeff; Frank Bergmann; Caroline Reiser; Esther Herpel; Helmut Friess; Peter Schirmacher; Markus W Büchler
Journal:  Ann Surg Oncol       Date:  2008-03-20       Impact factor: 5.344

3.  Redo-surgery following curative resection of pancreatic carcinoma: the difference between true and suspected recurrence.

Authors:  Matthias H Seelig; Monika Janot; Ansgar M Chromik; Torsten Herzog; Orlin Belyaev; Dirk Weyhe; Kirsten Meurer; Andreas Meiser; Andrea Tannapfel; Waldemar Uhl
Journal:  Dig Surg       Date:  2009-05-20       Impact factor: 2.588

Review 4.  New biomarkers and targets in pancreatic cancer and their application to treatment.

Authors:  Eithne Costello; William Greenhalf; John P Neoptolemos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-26       Impact factor: 46.802

5.  [R classification and pancreatic ductal adenocarcinoma--R 0 is R 0].

Authors:  J Munding; W Uhl; A Tannapfel
Journal:  Z Gastroenterol       Date:  2011-09-30       Impact factor: 2.000

6.  Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome.

Authors:  Deyali Chatterjee; Matthew H Katz; Asif Rashid; Gauri R Varadhachary; Robert A Wolff; Hua Wang; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Christopher Crane; Henry F Gomez; James L Abbruzzese; Jason B Fleming; Huamin Wang
Journal:  Cancer       Date:  2011-10-25       Impact factor: 6.860

7.  Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessment.

Authors:  Caroline Sophie Verbeke; Johannes Knapp; Ivar Prydz Gladhaug
Journal:  Histopathology       Date:  2011-12       Impact factor: 5.087

8.  A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status.

Authors:  Christian Wittekind; Carolyn Compton; Phil Quirke; Iris Nagtegaal; Susanne Merkel; Paul Hermanek; Leslie H Sobin
Journal:  Cancer       Date:  2009-08-01       Impact factor: 6.860

9.  Margin clearance and outcome in resected pancreatic cancer.

Authors:  David K Chang; Amber L Johns; Neil D Merrett; Anthony J Gill; Emily K Colvin; Christopher J Scarlett; Nam Q Nguyen; Rupert W L Leong; Peter H Cosman; Mark I Kelly; Robert L Sutherland; Susan M Henshall; James G Kench; Andrew V Biankin
Journal:  J Clin Oncol       Date:  2009-04-27       Impact factor: 44.544

10.  Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin.

Authors:  Fiona Campbell; Richard A Smith; Philip Whelan; Robert Sutton; Michael Raraty; John P Neoptolemos; Paula Ghaneh
Journal:  Histopathology       Date:  2009-09       Impact factor: 5.087

View more
  2 in total

Review 1.  [What is new in the pathology of pancreatic neuroendocrine tumors?].

Authors:  P Komminoth; A Perren
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

Review 2.  [Pathology of the R1 classification in visceral cancer surgery].

Authors:  M J Pollheimer; C Langner
Journal:  Chirurg       Date:  2017-09       Impact factor: 0.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.